BIOA vs AMPH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

BIOA

39.7
AI Score
VS
BIOA Wins

AMPH

35.3
AI Score

Investment Advisor Scores

BIOA

40score
Recommendation
AVOID NEW MONEY

AMPH

35score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric BIOA AMPH Winner
Forward P/E 0 0 Tie
PEG Ratio 0 2.77 Tie
Revenue Growth 1.6% 5.4% AMPH
Earnings Growth 0.0% 4.7% AMPH
Tradestie Score 39.7/100 35.3/100 BIOA
Profit Margin 0.0% 10.8% AMPH
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

BIOA 1M: -32.0% · 3M: -73.3% AMPH 1M: +6.1% · 3M: +28.4%

Current Technical Phase

BIOA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -36.9%), weak momentum, RSI 25

RSI (14): 25.2 · Price: $6.62

AMPH

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (9.5% over 20 days), RSI 57

RSI (14): 57.5 · Price: $25.19

Fundamentals Snapshot

Metric BIOA AMPH
Market Cap — —
Forward P/E -2.8 9.6
Trailing P/E — 15.3
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin -7.5% 0.5%
Operating Margin -12.0% 0.2%
EPS -2.39 1.69
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BIOA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.